Pablo Menéndez

8PUBLICATIONS
89CO-AUTHORS
Regenerative medicine (incl. stem cells)Medical molecular engineering of nucleic acids and proteinsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 02, 2024
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLLr B-ALL by regulating NR3C1 expression.

Belén Lopez-Millan, Alba Rubio-Gayarre, Meritxell Vinyoles

|Mar 04, 2024
CD155/PVR determines acute myeloid leukemia targeting by Delta One T cells.

Sofia Mensurado, Carolina Condeço, Diego Sánchez-Martínez

|Feb 14, 2024
Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo.

Laura Díez-Alonso, Aïda Falgas, Javier Arroyo-Ródenas

|Jan 04, 2024
Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression.

Oscar Molina, Carmen Ortega-Sabater, Namitha Thampi

Pageof 2